Ambifeb 40
Gout & Hyperuricemia

Ambifeb 40

Ambifeb 40 contains Febuxostat 40mg, a potent, non-purine selective inhibitor of xanthine oxidase. It is highly effective in reducing serum uric acid levels in patients with gout and hyperuricemia, offering a safer alternative for patients with mild-to-moderate renal impairment compared to traditional therapies.

Specifications

Composition

Febuxostat 40 mg Tablets

Pack Size

10 x 10 tablets (strip pack)

Minimum Order Qty

50 boxes

Storage Conditions

Store below 25°C in a dry place, protected from light

Shelf Life

24 months from date of manufacture

Certifications

GMP
WHO-GMP

Request a Quote

Interested in Ambifeb 40? Submit a quote request and our team will get back to you within 24 hours with institutional pricing.

Request Quote for This ProductGeneral Enquiry

MOQ: 50 boxes

All orders require a valid Drug License and GST registration.